Drug Profile
Buprenorphine depot - BioDelivery Sciences International/Evonik
Alternative Names: Buprenorphine long acting - BioDelivery Sciences International/Evonik; Buprenorphine microparticle depot - BioDelivery Sciences International/Evonik; Sustained release buprenorphine injection - BioDelivery Sciences InternationalLatest Information Update: 24 Mar 2022
Price :
$50
*
At a glance
- Originator Evonik
- Developer BioDelivery Sciences International; Evonik
- Class Cyclopropanes; Drug withdrawal therapies; Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Nociceptin receptor agonists; Opioid delta receptor agonists; Opioid kappa receptor antagonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Opioid-related disorders; Pain
Most Recent Events
- 22 Mar 2022 BioDelivery Sciences International has been acquired by Collegium Pharmaceutical
- 28 Jan 2020 No recent reports of development identified for preclinical development in Opioid-abuse in USA (SC, Controlled release)
- 28 Jan 2020 No recent reports of development identified for preclinical development in Pain in USA (SC, Controlled release)